Kauff et al. demonstrated that risk-reducing salpingo-oophorectomy is associated with an approximately 85% risk reduction of BRCA1-associated gynecologic cancer and 72% risk reduction of BRCA2-associated BC. The gene discussed is BRCA2; the disease is breast cancer.